Furthermore, studies on rheumatology related disorders such as ankylosing spondylitis [54] and rheumatoid arthritis [55], which share a common inflammatory molecular background with IBD, have shown prior involvement of the microbiome in disease progression and treatment with anti-TNF. This evidence concerns the gene TNF and inflammatory bowel disease.